Kronos Bio, Inc.盘中异动股价大涨5.32%报0.970美元

市场透视10-14

北京时间2024年10月14日22时04分，Kronos Bio, Inc.（KRON.us）股票出现波动，股价快速拉升5.32%。截至发稿，该股报0.970美元/股，成交量1748股，换手率0.00%，振幅3.79%。最近的财报数据显示，该股实现营业收入2.69百万美元，净利润-16.20百万美元，每股收益-0.27美元，毛利2.27百万美元，市盈率-0.53倍。机构评级方面，目前暂无机构对该股...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2475984663?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-14 22:04","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2475984663","market":"us","top_or_hot":-1,"title":"Kronos Bio, Inc.盘中异动 股价大涨5.32%报0.970美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月14日22时04分，Kronos Bio, Inc.（KRON.us）股票出现波动，股价快速拉升5.32%。截至发稿，该股报0.970美元/股，成交量1748股，换手率0.00%，振幅3.79%。最近的财报数据显示，该股实现营业收入2.69百万美元，净利润-16.20百万美元，每股收益-0.27美元，毛利2.27百万美元，市盈率-0.53倍。机构评级方面，目前暂无机构对该股...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014220413ab69fdc9&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kronos Bio, Inc.盘中异动 股价大涨5.32%报0.970美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKronos Bio, Inc.盘中异动 股价大涨5.32%报0.970美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-14 22:04 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014220413ab69fdc9&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月14日22时04分，Kronos Bio, Inc.（KRON.us）股票出现波动，股价快速拉升5.32%。截至发稿，该股报0.970美元/股，成交量1748股，换手率0.00%，振幅3.79%。最近的财报数据显示，该股实现营业收入2.69百万美元，净利润-16.20百万美元，每股收益-0.27美元，毛利2.27百万美元，市盈率-0.53倍。机构评级方面，目前暂无机构对该股...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014220413ab69fdc9&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4505","symbol_name":"高瓴资本持仓","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014220413ab69fdc9&s=b","article_id":"2475984663","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014220413ab69fdc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2475984663","pubTimestamp":1728914653,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月14日22时04分，Kronos Bio, Inc.股票出现波动，股价快速拉升5.32%。截至发稿，该股报0.970美元/股，成交量1748股，换手率0.00%，振幅3.79%。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4505":"高瓴资本持仓","KRON":"Kronos Bio, Inc.","BK4139":"生物科技"},"translate_title":"Kronos Bio, Inc. shares jumped 5.32% to $0.970 in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KRON":1},"content_text":"北京时间2024年10月14日22时04分，Kronos Bio, Inc.（KRON.us）股票出现波动，股价快速拉升5.32%。截至发稿，该股报0.970美元/股，成交量1748股，换手率0.00%，振幅3.79%。最近的财报数据显示，该股实现营业收入2.69百万美元，净利润-16.20百万美元，每股收益-0.27美元，毛利2.27百万美元，市盈率-0.53倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Kronos Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)、Longboard Pharmaceuticals, Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Aditxt, Inc.、Rani Therapeutics Holdings, Inc.、Longboard Pharmaceuticals, Inc.较为活跃，换手率分别为133.93%、65.29%、49.16%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)、Jasper Therapeutics Inc C/Wts 24/09/2026 (To Pur Com)、Jasper Therapeutics, Inc.，振幅分别为114.09%、33.33%、30.31%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。该公司在一个业务部门运营，即生物制药产品的开发。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2475984663"}

Kronos Bio, Inc.盘中异动 股价大涨5.32%报0.970美元

精彩评论

Kronos Bio, Inc.盘中异动股价大涨5.32%报0.970美元